Alnylam Pharmaceuticals Inc Note 1.000 9/1 shares owned by Palisade Capital Management
Quarter-by-quarter ownership of Alnylam Pharmaceuticals Inc Note 1.000 9/1 shares owned by Palisade Capital Management
from 13F filings
Historical chart of Palisade Capital Management investment in Alnylam Pharmaceuticals Inc Note 1.000 9/1
Tip: Access up to 7 years of quarterly data
All positions including Alnylam Pharmaceuticals Inc Note 1.000 9/1 held by Palisade Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Alnylam Pharmaceuticals Inc Note 1.000 9/1 by Palisade Capital Management
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-03-31 | $460k | 489k | 0.94 |
2023-12-31 | $620k | 629k | 0.99 |
2023-09-30 | $582k | 629k | 0.93 |
More positions owned by Palisade Capital Management
View all positions for Palisade Capital Management
Top funds holding Alnylam Pharmaceuticals Inc Note 1.000 9/1
View all funds holding Alnylam Pharmaceuticals Inc Note 1.000 9/1